Overview

Budesonide for Maintenance Treatment of Collagenous Colitis

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.
Phase:
Phase 3
Details
Lead Sponsor:
Technische Universität Dresden
Collaborator:
AstraZeneca
Treatments:
Budesonide